Garofalo A. Elizabeth's Insider Trades & SAST Disclosures
Garofalo A. Elizabeth's most recent trade in Acadia Pharmaceuticals Inc was a trade of 4,919 Common Stock done at an average price of $18.2 . Disclosure was reported to the exchange on March 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Garofalo A. Elizabeth.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Sale of securities on an exchange or to another person at price $ 18.23 per share. | 05 Mar 2025 | 4,919 | 17,595 (0%) | 0% | 18.2 | 89,673 | Common Stock |
| Alector Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 35,000 | 61,250 (0%) | 0% | 0 | Common Stock | |
| Xenon Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 15,542 | 15,542 | - | - | Stock Option (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 15,959 | 15,959 | - | - | Director Stock Options (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 9,387 | 9,387 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 6,652 | 0 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 6,652 | 22,514 (0%) | 0% | - | Common Stock | |
| Xenon Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.56 per share. | 08 Mar 2024 | 3,500 | 3,500 (0%) | 0% | 18.6 | 64,960 | Common Shares |
| Xenon Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 3,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Sale of securities on an exchange or to another person at price $ 45.69 per share. | 08 Mar 2024 | 2,092 | 0 (0%) | 0% | 45.7 | 95,583 | Common Shares |
| Xenon Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.16 per share. | 08 Mar 2024 | 1,408 | 2,092 (0%) | 0% | 46.2 | 64,993 | Common Shares |
| Alector Inc | Garofalo A. Elizabeth | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 9,459 | 26,250 (0%) | 0% | 0 | Common Stock | |
| Alector Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 26,250 | 35,709 (0%) | 0% | 0 | Common Stock | |
| Alector Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,360 | 12,360 | - | - | Stock Option (right to buy) | |
| Xenon Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 18,475 | 18,475 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2022 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Alector Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 18,918 | 18,918 | - | - | Stock Option (right to buy) | |
| Alector Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 9,459 | 9,459 (0%) | 0% | 0 | Common Stock | |
| Exicure Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 14,368 | 14,368 | - | - | Director Stock Options (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 11,045 | 11,045 | - | - | Director Stock Options (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 8,552 | 0 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 8,552 | 18,780 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 8,552 | 8,552 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 6,652 | 6,652 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 6,391 | 0 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 6,391 | 8,309 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 1,919 | 0 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 1,919 | 10,228 (0%) | 0% | - | Common Stock | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2021 | 1,918 | 1,919 | - | - | Restricted Stock Units | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2021 | 1,918 | 1,918 (0%) | 0% | - | Common Stock | |
| Alector Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2021 | 33,235 | 33,235 | - | - | Stock Option (right to buy) | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 11,637 | 11,637 | - | - | Director Stock Options (Right to Buy) | |
| Acadia Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 6,391 | 6,391 | - | - | Restricted Stock Units | |
| Xenon Pharmaceuticals Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Exicure Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Exicure Inc | Elizabeth A. Garofalo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges